feed,title,long_url,short_url
Benzinga,Ultimovacs Starts Clinical Evaluation of Novel TET-Platform with Phase I TENDU Study Investigating Prostate Cancer-Specific Therapeutic Vaccine,https://www.benzinga.com/pressreleases/21/02/b19720872/ultimovacs-starts-clinical-evaluation-of-novel-tet-platform-with-phase-i-tendu-study-investigating,https://j.mp/37nY4en
